In this episode of Conquer Your Weight, Dr. Sarah Stombaugh discusses the newly approved higher-dose version of semaglutide, Wegovy HD (7.2 mg). She reviews the latest clinical trial data showing how effective the higher dose is for weight loss and how it compares to the standard 2.4 mg Wegovy dose.

Dr. Stombaugh also explains the side effect profile of the higher dose, what patients can expect during treatment, and how clinicians help manage common GLP-1 side effects.

Finally, she compares Wegovy HD to Zepbound (tirzepatide) and discusses how to think about choosing the right medication based on effectiveness, tolerability, and individual goals.

Ready to get started on your weight loss journey? We’re now enrolling patients for in-person visits in Charlottesville, Virginia, and for telemedicine throughout the states of Illinois, Tennessee, and Virginia. Learn more and get started today at https://www.sarahstombaughmd.com

If you’re looking for support during your GLP journey, check out The GLP Guide. This on-demand video program will give you answers to the questions you have! Get started today at https://www.sarahstombaughmd.com/glp